Jefferies Maintains a 'Hold' on City National (CYN); Softer NIM Compression Lifts Estimates
CYN Hot Sheet
Rating Summary:5 Buy, 9 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 20 | Down: 11 | New: 38
Jefferies maintains a 'Hold' on City National (NYSE: CYN) price target raised from $43 to $47.
Jefferies analyst says, "We raise our estimates modestly following a slightly better net interest margin result in 4Q, but remain at the low end of a wide range in consensus. FDIC accounting continues to make earnings forecast difficult, but we see EPS runrates falling short of the $0.90/quarter level implied by consensus without a more aggressive capital return policy and/or expense controls."
(FY12 EPS estimate from $3.25 to $3.35 and FY13 from $3.45 to $3.60)
For an analyst ratings summary and ratings history on City National click here. For more ratings news on City National click here.
Shares of City National closed at $46.15 yesterday, with a 52 week range of $35.07-$61.22.
Discover Wall Street's best ratings calls with the pros - Ratings Insider Elite. Free Trial!
Jefferies analyst says, "We raise our estimates modestly following a slightly better net interest margin result in 4Q, but remain at the low end of a wide range in consensus. FDIC accounting continues to make earnings forecast difficult, but we see EPS runrates falling short of the $0.90/quarter level implied by consensus without a more aggressive capital return policy and/or expense controls."
(FY12 EPS estimate from $3.25 to $3.35 and FY13 from $3.45 to $3.60)
For an analyst ratings summary and ratings history on City National click here. For more ratings news on City National click here.
Shares of City National closed at $46.15 yesterday, with a 52 week range of $35.07-$61.22.
Discover Wall Street's best ratings calls with the pros - Ratings Insider Elite. Free Trial!
You May Also Be Interested In
- UPDATE: Auriga Starts Teva Pharma (TEVA) at Hold; Sidelined Until New CEO Is Convincing
- UBS Raises Price Target and Estimates on PetSmart (PETM); Sees Sustained Sales and Margin Benefit
- Barclays Maintains an 'Equalweight' on J. C. Penney (JCP); Slashing PT on Disappointing Results
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Jefferies & Co, FDIC, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
